Abstract
Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have